Licensing deal for Penthrox in Australia
3 June 2019
ASX ANNOUNCEMENT
Licensing deal for Penthrox in Australia
Medical Developments International Limited (ASX: MVP) is delighted to announce it has reached agreement with Mundipharma Pty Ltd (Mundipharma) for the exclusive distribution rights of Penthrox® in Australia.
Mr. John Sharman, Chief Executive Officer of MVP, said: “This is an exciting deal for MVP because Mundipharma has a respected presence in the pain market with broad sales force coverage across Australia. This presence in the field is expected to lead to impressive sales growth in the short to medium term, particularly within General Practitioner and Hospital channels.”
For the full announcement please click on the following link – ASX Announcement – Licensing deal for Penthrox in Australia